Abdo Jurjus

Dr. Abdo Jurjus


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2004 in Journal of Pharmacological and Toxicological Methods
Verified
Journal Article
Closed access
AJAbdo Jurjus
Abdo Jurjus
NKNaim N. Khoury
Naim N. Khoury
JRJean-Marie Reimund
Jean-Marie Reimund

3 October 2016 in Current Hypertension Reports
Verified
Journal Article
Closed access
PDF file
SMSamir G. Mallat
Samir G. Mallat
SKSahar Al Kattar
Sahar Al Kattar
BTBassem Y. Tanios
Bassem Y. Tanios
AJAbdo Jurjus
Abdo Jurjus

7 July 2015 in BioMed Research International
Verified
Journal Article
Open access
PDF file
FGFadi Ghieh
Fadi Ghieh
RJRosalyn Jurjus
Rosalyn Jurjus
AIAmir Ibrahim
Amir Ibrahim
AGAlice Gerges Geagea
Alice Gerges Geagea
HDHisham Daouk
Hisham Daouk
AJAbdo Jurjus
Abdo Jurjus
Burn wound healing involves a series of complex processes which are subject to intensive investigations to improve the outcomes, in particular, the healing time and the quality of the scar. Burn injuries, especially severe ones, are proving to have devastating effects on the affected patients. Stem cells have been recently applied in the field to promote superior healing of the wounds. Not only have stem cells been shown to promote better and faster healing of the burn wounds, but also they have decreased the inflammation levels with less scar progression and fibrosis. This review aims to highlight the beneficial therapeutic effect of stem cells in burn wound healing and to discuss the involved pathways and signaling molecules. The review covers various types of burn wound healing like skin and corneal burns, along with the alternative recent therapies being studied in the field of burn wound healing. The current reflection of the attitudes of people regarding the use of stem cells in burn wound healing is also stated.

7 July 2005 in Journal of Human Hypertension
Verified
Journal Article
Closed access
RTR A Tohme
R A Tohme
AJAbdo Jurjus
Abdo Jurjus
AEA Estephan
A Estephan

3 March 2014 in Anatomical Sciences Education
Verified
Journal Article
Closed access
PDF file
AJAbdo Jurjus
Abdo Jurjus
JLJuliet Lee
Juliet Lee
SASamantha Ahle
Samantha Ahle
KBKirsten M. Brown
Kirsten M. Brown
GBGisela Butera
Gisela Butera
JKJill M. Krapf
Jill M. Krapf

10 July 2020 in Cancers
Verified
Journal Article
Open access
PDF file
SKSahar Al kattar
Sahar Al kattar
RJRosalyn Jurjus
Rosalyn Jurjus
APAline Pinon
Aline Pinon
DLDavid Yannick Leger
David Yannick Leger
AJAbdo Jurjus
Abdo Jurjus
BLBertrand Liagre
Bertrand Liagre
The co-occurrence of colorectal cancer (CRC) and diabetes mellitus along with inflammation and dismicrobism has been frequently reported. Several studies shed light on the antioncogenic potential of metformin on colorectal carcinogenesis. This study aimed to demonstrate that metformin in association with probiotics acts in a synergic effect in breaking the crosstalk, thus inhibiting CRC progression, improving diabetes, and reducing inflammation. Ninety-six male Balb/c mice, 6–8 weeks old, were divided into 16 control and experimental groups to assess the effect of the different treatments and combinations at the clinical, histological, and molecular levels. Metformin and probiotics showed beneficial outcomes on CRC and diabetes, alone and most importantly in combination. Their effects were exerted by inhibiting the inflammatory process whereby a downregulation of IL-6 and TNF-α as well as oxidative stress were depicted. The characterization of the effects of probiotics and metformin on CRC and diabetes sheds light on the role of inflammation and microbiota in this crosstalk. Deciphering the downstream signaling pathways elicited by these compounds will help in developing new effective targeted treatment modalities.